Pharmaceutical company in the
Canton of Ticino

Bioggio Pharma Manufacture SA

Since 1973 · 51–100 empl.

Bioggio Pharma Manufacture SA is a contract development and manufacturing organisation for pharmaceutical and nutraceutical products. The company provides services across design, development and delivery, as well as private label solutions and manufacturing support.

Evultis SA

Since 1978 · 1–10 empl.

Evultis SA trades in active pharmaceutical ingredients and intermediates, supplying the pharmaceutical industry with ingredients and solutions for human and animal health. Its activities also cover nutraceuticals, cosmetics and hygiene products, as well as specialized logistics services.

Kamfarma SA

Since 1978 · 11–20 empl.

Kamfarma SA is a pharmaceutical company involved in the development of medicines and active pharmaceutical ingredients. Its activities include developing API synthesis processes and finished dosage forms, as well as managing projects for pharmaceutical production facilities.

Cerbios-Pharma SA

Since 1979 · 51–100 empl.

The core activity of Cerbios-Pharma SA is the development and manufacturing of pharmaceutical active ingredients (APIs), in particular highly potent active ingredients (HPAPIs), antibody-drug conjugates (ADCs) and biologics, as a Contract Development and Manufacturing Organization (CDMO).

Fordras SA

Since 1983 · 101–500 empl.

Fordras SA is Bioseutica Group’s commercial branch for pharmaceutical ingredients, serving the pharmaceutical and food industries. It produces and distributes products including enzymes such as lysozyme, and conducts research and development into biological products and their applications.

Chemo Project SA

Since 1984 · 21–50 empl.

The core activity of Insud Pharma is the development, manufacture and marketing of pharmaceutical products. The company operates in the healthcare sector and offers innovative solutions for healthcare. The core activities include research and development (15 research and development centers), production (20 industrial facilities) and distribution of medicines.

Altergon SA

Since 1985 · 1–10 empl.

Zambon Switzerland Ltd

Since 1987 · 21–50 empl.

The core activity of Zambon is the development, manufacture and marketing of pharmaceuticals.

VB Technochemicals SA

Since 1993 · 1–10 empl.

VB Technochemicals SA operates in the chemical and pharmaceutical products sector. It supplies barium and zinc derivatives and distributes pharmaceutical products, with services covering product registration, launch and marketing.

Osmopharm SA

Since 1994 · 1–10 empl.

The core activity of Osmopharm SA is the development and production of modified oral dosage forms, particularly in pellet, tablet or resin form, using advanced galenic technologies such as coating, extrusion-spheronization and ion exchange. The company also offers services such as the manufacture of hard gelatin capsules or tablets, capsule filling and packaging of pharmaceuticals. Additionally, Osmopharm supports its customers in preparing registration applications and conducting regulatory activities.

Refarmed Chemicals SA

Since 1995 · 21–50 empl.

The core activity of Refarmed Chemicals Ltd. is the distribution of pharmaceutical active ingredients (Active Pharmaceutical Ingredients, API) and finished dosage forms (Finished Dosage Form, FDF) for the generic pharmaceutical industry.

Polichem SA, Lussemburgo, succursale di Mendrisio

Since 1997 · 11–20 empl.

Polichem SA, Lussemburgo, succursale di Mendrisio researches, develops, manufactures and markets its own medicines and licensed products. Its portfolio includes products in dermatology, gynaecology, neurology and respiratory medicine.

Inceptua SA, Luxembourg, Succursale di Bioggio

Since 1997 · 1–10 empl.

Inceptua SA, Luxembourg, Succursale di Bioggio is part of Inceptua Group, a pharmaceutical services company. The group sources and distributes medicines for clinical trials and early access programmes, and provides clinical services including packaging, labelling, storage and logistics.

PharmaCina - DHAO SA

Since 2000 · 1–10 empl.

PharmaCina - DHAO SA is a traditional Chinese medicine laboratory that imports Chinese herbs and produces herbal preparations. Its products include herbs for decoctions, granules, honey tablets and herbal mixtures; prescription preparations are made for qualified prescribers.

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA

Since 2003 · 11–20 empl.

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA develops and manufactures pharmaceutical products and dietary supplements, particularly custom-made and ready-to-order effervescent tablets. It also develops formulations and technologies for products in the pharmaceutical, nutrition and cosmetics sectors.

NANONICA SA

Since 2006 · 1–10 empl.

NANONICA SA facilitates the transfer of knowledge from academia to industry in nanotechnology and microtechnology. It develops and commercializes research results, with applications including medicine, energy and environmental science.

Walter Pierpaoli Sagl

Since 2006 · 11–20 empl.

The core activity of Pierpaoli Exelyas Srl is the development and production of products based on the research and findings of Professor Walter Pierpaoli, particularly in the field of Neuro-Endocrino-Immuno-Modulation (NEIM) and the regulation of biological rhythms through melatonin. The products aim to promote the body's biological balance, slow down aging and maintain health.

CHEMO AG, Vienna, Lugano Branch

Since 2006 · 1–10 empl.

CHEMO AG, Vienna, Lugano Branch operates in the pharmaceutical sector as part of Insud Pharma’s Chemo industrial business. Chemo researches, develops and manufactures active pharmaceutical ingredients and finished dosage forms for human and veterinary use, and provides contract manufacturing services.

Lallemand Pharma AG

Since 2007 · 11–20 empl.

Lallemand Pharma AG develops and commercializes medicines and medical devices for respiratory conditions. Its products include sublingual tablets containing PMBL bacterial lysate and Healsea nasal sprays.

CoreQuest Sagl

Since 2008 · 1–10 empl.

CoreQuest Sagl is a pharmaceutical company that researches and develops medicines and medical devices for nephrology and surgery. Its activities include solutions for peritoneal dialysis and the development of a therapeutic platform for congestive heart failure.

ROELMI HPC SWISS SA

Since 2008 · 1–10 empl.

ROELMI HPC SWISS SA develops and produces ingredients for the personal care, nutraceutical and food markets. It conducts research and development and supports customers with the formulation and production of customised products.

Humabs BioMed SA

Since 2011 · 11–20 empl.

The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.

Valentis AG

Since 2011 · 101–500 empl.

Valentis AG is an international pharmaceutical company that develops and manufactures food supplements, medical devices and herbal health products. Its activities include research and product development, contract manufacturing, packaging and logistics, with a focus on liquid nutraceuticals and microcapsule technologies.

Swiss Applied Coating Research (S.A.C.R.) GmbH

Since 2011 · 1–10 empl.

Swiss Applied Coating Research (S.A.C.R.) GmbH develops and produces solid oral dosage forms for the pharmaceutical, nutraceutical and food industries, with a focus on film coating using natural polymers. Its services also include consultancy, tailored coating formulations, technical support and maintenance for coating equipment.

MABXIENCE SA

Since 2012 · 101–500 empl.

MABXIENCE SA develops and manufactures biopharmaceutical medicines, including biosimilars. It also provides integrated contract development and manufacturing services (CDMO) for biologics.

ADIENNE SA

Since 2012 · 21–50 empl.

ADIENNE SA is a biopharmaceutical company that develops and markets medicines for rare and severe diseases. It also provides contract development and manufacturing services for pharmaceutical products, including analytical and formulation development, process development and commercial manufacturing.

Cures Healthcare Ltd

Since 2012 · 11–20 empl.

Cures Healthcare Ltd is a specialty-branded pharmaceutical company offering project solutions, including technology-transfer projects with international partners. Its activities include pharmaceutical product registration, market entry and marketing, and it offers medicines for export.

Seegpharm SA

Since 2012 · 1–10 empl.

Seegpharm SA co-develops complex generic medicines with partners and out-licenses these products. Its activities also include developing synthesis routes for active ingredients and finished dosage forms, as well as promoting and distributing selected patented products.

Fondazione Ceschina

Since 2013 · 1–10 empl.

Fondazione Ceschina supports scientific and clinical research into rare diseases, with particular attention to immune-mediated inflammatory conditions such as spondyloarthropathies. It funds academic research projects and organizes scientific meetings.

H.E. ADVANCED NUTRITION SA

Since 2013 · 11–20 empl.

The core activity of HE Advanced Nutrition SA is the research and production of nutraceutical and pharmaceutical products, particularly food supplements and medicines, with innovative formulations and the highest quality standards.

ADIENNE Pharma & Biotech SA

Since 2013 · 101–500 empl.

ADIENNE Pharma & Biotech SA develops and markets medicines for rare and severe diseases, with a focus on haematological and immunological conditions. It also provides pharmaceutical development and manufacturing services, including for sterile medicines and biologics.

PHARMA TICINO SA

Since 2014 · 1–10 empl.

PHARMA TICINO SA provides pharmaceutical consulting to pharmaceutical companies and outsourcing services for healthcare organisations, including accounting, human resources and activity planning. It also develops regional healthcare services such as medical practices, pharmacies and gyms.

MAS pharma SA

Since 2015 · 1–10 empl.

MAS pharma SA operates pharmacies offering medicines, supplements, cosmetics and healthcare products. Its services include consultations on different therapeutic approaches, clinical analyses and individually prepared galenic medicines.

Cronet Sagl

Since 2015 · 1–10 empl.

Cronet Sagl is a consulting company providing scientific and regulatory support to the pharmaceutical, biotechnology, and medical device industries. Its services include regulatory consulting, preclinical study design and management, risk assessment, and project coordination.

PHARGENTIS SA

Since 2015 · 11–20 empl.

PHARGENTIS SA develops complex dosage forms for early-market-entry generics and SuperGeneric products. The pharmaceutical company focuses particularly on respiratory treatments and licenses products to pharmaceutical partners for market access.

MADDOX Pharma Swiss GmbH

Since 2015 · 1–10 empl.

MADDOX Pharma Swiss GmbH develops and supplies pharmaceutical products and food supplements. The company describes quality controls and product monitoring throughout the product lifecycle.

GT Gain Therapeutics SA

Since 2017 · 11–20 empl.

GT Gain Therapeutics SA develops small-molecule allosteric therapies for neurodegenerative diseases and rare genetic disorders. Its Magellan platform combines AI-supported structural biology with physics-based models for drug discovery, and its candidate rexaceract is being clinically evaluated for Parkinson’s disease.

PROBIONOVA SA

Since 2018 · 11–20 empl.

PROBIONOVA SA conducts research and development on probiotic applications for human health. It produces individual probiotic strains and premixes, and supports the development of probiotic products from concept and validation through to production.